O psychologické podpoře pacientů s viditelnými dermatózami

PhDr. Václav Mertin

Dermatol. praxi. 2018;12(4):159  

Local therapy of inflammatory (papulopustular) lesions of rosacea in adult patients

MUDr. Radana Dwayebová

Dermatol. praxi. 2018;12(4):164-166 | DOI: 10.36290/der.2018.041  

Papulopustular rosacea is a moderately severe form of facial dermatitis. It is characterized by the development of papules andpapulopustules on a permanently reddened skin. Cutaneous manifestations are situated in the central part of the face. There areseveral pathophysiological models of rosacea. Local therapy involves a number of external drugs aimed at relieving inflammatorysymptoms. Recently, ivermectin 1% cream has become the drug of choice in this subtype of rosacea, with its anti-inflammatoryand antiparasitic effects being utilized as well. Because of the simultaneous presence of persistent erythema, a recommendedcombination of ivermectin with...

Topical treatment of psoriasis

MUDr. Zuzana Baranová, PhD.

Dermatol. praxi. 2018;12(4):167-170 | DOI: 10.36290/der.2018.029  

This article presents an overview of options for topical treating psoriasis. Although a wide range of topical and systemictreatments are available, no psoriasis treatment is universally effective. Treatment depends on the location of lesions, theirsize, the amount of the skin affected, previous response to treatment, and preferences for treatment. Topical therapiesinclude moisturizer, keratolytic agents, coal tar, anthralin, topical corticosteroids, topical vitamin D3, tazarotene. Patientswith middle to moderate psoriasis are treated initially with topical treatments, Topical treatments are often inexpensive andefficacious and have a very good safety...

Current trends in the therapy od seborrheic dermatitis

MUDr. Jana Földesová

Dermatol. praxi. 2018;12(4):173-176 | DOI: 10.36290/der.2018.030  

Seborrheic dermatitis is a chronic relapsing disease affecting areas rich with sebaceous glands and intertrginous areas. The articlenot only covers the etiology and clinical picture, but also available therapy, it ´s combinations and prevention.

Impetigo – diagnosis and treatment

MUDr. Táňa Pappová, PhD., MUDr. Andrea Kozárová, PhD.

Dermatol. praxi. 2018;12(4):178-181 | DOI: 10.36290/der.2018.042  

Impetigo is the most common contagious bacterial infection of the skin affecting mainly children aged between 2 and 5 yearswith the highest incidence in tropical and subtropical climates. Historically, impetigo has been considered a mild skin infection,but in case of insufficient treatment, it can lead to serious clinical disorders. Systemic antibiotics present the first line therapy inwidespread lesions of impetigo. Currently, the increasing prevalence of antibiotic resistance may cause difficulty in managementof impetigo with adverse consequences not only for individuals but also for population.

Current perspective on treating herpes zoster and postherpetic neuralgia

MUDr. Marek Pieran

Dermatol. praxi. 2018;12(4):182-185 | DOI: 10.36290/der.2018.043  

Postherpetic neuralgia (PHN) is a relatively frequent and stubborn complaint. The treatment is difficult given the irreversiblepathophysiological and anatomical changes in the neural structures, inadequate effect, and questionable tolerability to thetreatment recommended. The article summarizes the current options of analgesia and evaluation of their success rates in thecontext of IASP (International Association for the Study of Pain) experts’ recommendations.

Selected viral exanthema in children

doc. RNDr. Vanda Boštíková, Ph.D., doc. MUDr. Miloslav Salavec, CSc., Mgr. Ivana Holmquist, Ing. Hana Střítecká, Ph.D.

Dermatol. praxi. 2018;12(4):186-190  

Children could be affected by the classic rash, the allergic rash, even by the parainfectious rash, thankful to viral or bacterial infection.In the following article we describe mainly viral parainfectious rashes on the skin, which may occur as a result of interactionwith human immune system.

Successful treatment of hidradenitis suppurativa in young woman

MUDr. Petra Fialová, prof. MUDr. Vladimír Vašků, CSc.

Dermatol. praxi. 2018;12(4):191-194 | DOI: 10.36290/der.2018.031  

Hidradenitis suppurativa (HS) is a chronic recurrent inflammatory disease affecting mainly young active people. The frequencyof HS is three times higher among females than men. HS is characterized by deep painful nodules in apocrine gland areas. HShas negative impact on patient‘s quality of life involving physical, social and economic aspects. The treatment of HS dependson severity of the disease and on its activity. The combined treatment – medical and surgical is prefered for the patients withsevere form of the disease. This case report describes a young woman with severe form of HS and its succesful treatment withcombination of antibiotics,...

Long-term omalizumab therapy in a patient with severe chronic spontaneous urticaria

MUDr. Olga Filipovská

Dermatol. praxi. 2018;12(4):196-198 | DOI: 10.36290/der.2018.045  

Case report describes long-term cyclic therapy with omalizumab in a young patient with a severe form of chronic spontaneousurticaria (CSU), not responding to the treatment of increased dose H1-antihistamines and the corticosteroid therapy. The patienthas completed 6 cycles of therapy during last two years, each with an excellent effect.

Enterosorbent ENTEROSGEL in the complex treatment of atopic eczema

doc. MUDr. Jaromír Bystroň, CSc., MUDr. Lubomír Heller, MUDr. Iva Karlová, MUDr. Zora Poláčková

Dermatol. praxi. 2018;12(4):199-203 | DOI: 10.36290/der.2018.032  

The authors present the results of a prospective, multicenter, controlled clinical trial that looked at the effect of ENTEROSGEL,the hydrogel of methyl silicic acid available as a medical device, in patients with moderate to severe atopic eczema. The authorsfollowed the symptom score in patients 15 days before dosing and 30 days of enterosorbent administration and within six monthsafter the end of dosing. At the same time, they evaluated the basic biochemical values of blood serum, tolerability and subjectiveevaluation of the effect of the studied product on individual patients. The primary endpoint of the study was confirmed in the19 subjects evaluated...

Využití Enstilar® pěny u ložiskové psoriázy
Pilotní studie po dobu 12 týdnů, hodnocení v 4. a 10. týdnu

MUDr. Jitka Bočková

Dermatol. praxi. 2018;12(4):207-209  

Vybrané poznatky z 27. kongresu Evropské akademie dermatologie a venerologie (EADV) v Paříži ve dnech 12.–16. 9. 2018

doc. MUDr. Karel Ettler, CSc.

Dermatol. praxi. 2018;12(4):210-211  

Irregularly pigmented lesions in childhood

MUDr. Veronika Paťavová, MUDr. Lubomír Drlík

Dermatol. praxi. 2018;12(4):204-206 | DOI: 10.36290/der.2018.046  

The authors describe two clinically similar cases with different diagnosis. The lesions were flat, irregularly pigmented on theextremities of juveniles, which is not a typical sign for Spitz nevi (missing pink color).